Regulation of vascular endothelial growth factor expression by insulin- like growth factor-I in endometrial adenocarcinoma cells

International Journal of Cancer

Volumn 85, Issue 1, 2000, Pages 117-123

  Bermont, Laurent ^a   Lamielle, Frédérique ^a   Fauconnet, Sylvie ^a   Esumi, Hiroyasu ^b   Weisz, Alessandro ^c   Adessi, Gérard L ^a,d  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Inst d'Etud de Transfert de Genes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; SOMATOMEDIN C; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ARTICLE; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ALTERNATIVE SPLICING; BLOTTING, NORTHERN; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHOKINES; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033991061     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000101)85:1<117::AID-IJC21>3.0.CO;2-X     Document Type: Article

References (34)

1. AMBROSINO, C., CICATIELLO, L., COBELLIS, G., ADDEO, R., SICA, V., BRESCIANI, F. and WEISZ, A., Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. Mol Endocrinol., 7, 1472-1483 (1993).
2. CASTRO-RIVERA, E. and SAFE, S., Estrogen-and antiestrogen-responsiveness of HEC-1A endometrial adenocarcinoma cells in culture. J. Steroid Biochem. Mol. Biol., 64, 287-295 (1998).
3. CHALBOS, D., PHILIPS, A. and ROCHEFORT, H., Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Semin. Cancer Biol., 5, 361-368 (1994).
4. CHARNOCK-JONES, D.S., SHARKEY, A.M., RAJPUT-WILLIAMS, J., BURCH, D., SCHOFIELD, J.P., FOUNTAIN, S.A., BOOCOCK, C.A. and SMITH, S.K., Identification and localization of alternatively spliced mRNAs vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128 (1993).
5. CHIN, K., KURASHIMA, Y., OGURA, T., TAJIRI, H., YOSHIDA, S. and ESUMI, H., Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene, 15, 437-442 (1997).
6. FELDKAMP, M.M., LAU, N., RAK, J., KERBEL, R.S. and GUHA, A., Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int. J. Cancer, 81, 118-124 (1999).
7. FERRARA, N. and HENZEL, W.J., Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. biophys. Res. Comm., 161, 851-858 (1989).
8. FERRARA, N., HOUCK, K., JAKEMAN, L. and LEUNG, D.W., Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev., 13, 18-32 (1992).
9. FOLKMAN, J., The role of angiogenesis in tumor growth. Semin. Cancer biol., 3, 65-71 (1992).
10. GIUDICE, L.C., MILKOWSKI, D.A., LAMSON, G., ROSENFELD, R.G. and IRWIN, J.C., Insulin-like growth factor binding proteins in human endometrium: steroid-dependent messenger ribonucleic acid expression and protein synthesis. J. clin. Endocrinol. Metab., 72, 779-787 (1991).
11. GOAD, D.L., RUBIN, J., WANG, H., TASHJIAN, JR., A.M. and PATTERSON, C., Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology, 137, 2262-2268 (1996).
12. GOSPODAROWICZ, D., ABRAHAM, J.A. and SCHILLING, J., Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. nat. Acad. Sci. (Wash.), 86, 7311-7315 (1989).
13. GUIDI, A.J., ABU-JAWDEH, G., TOGNAZZI, K., DVORAK, H.F. and BROWN, L.F., Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer. 78, 454-460 (1996).
14. HOUCK, K.A., LEUNG, D.W., ROWLAND, A.M., WINER, J. and FERRARA, N., Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J biol. Chem., 267, 26031-26037 (1992).
15. INOUE, Y., OBATA, K., ABE, K., OHMURA, G., DOH, K., YOSHIOKA, T., HOSHIAI, H. and NODA, K., The prognostic significance of vascular invasion by endometrial carcinoma. Cancer, 78, 1447-1451 (1996).
16. KIM, K.J., LI, B., WINER, J., ARMANINI, M., GILLETT, N., PHILLIPS, H.S. and FERRARA, N., Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth In vivo. Nature (Lond.), 362, 841-844 (1993).
17. KOURA, A.N., LIU, W., KITADAI, Y., SINGH, R.K., RADINSKY, R. and ELLIS, L.M., Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res., 56, 3891-3894 (1996).
18. LEVY, N.S., CHUNG, S., FURNEAUX, H. and LEVY, A.P., Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. biol. Chem., 273, 6417-6423 (1998).
19. MA, W.J., CHENG, S., CAMPBELL, C., WRIGHT, A. and FURNEAUX, H., Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. biol. Chem., 271, 8144-8151 (1996).
20. MACK, T.M., PIKE, M.C., HENDERSEN, B.E., PFEFFER, R.I., GERKINS, V.R., ARTHUR, M. and BROWN, S.E., Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med., 294, 1262-1267 (1976).
21. MINCHENKO, A., SALCEDA, S., BAUER, T. and CARO, J., Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell mol. biol. Res., 40, 35-39 (1994).
22. MUKHOPADHYAY, D., TSIOKAS, L., ZHOU, X.M., FOSTER, D., BRUGGE, J.S., SUKHATME, V.P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375, 577-581 (1995).
23. MURPHY, L.J. and GHAHARY, A., Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocrinol. Rev., 11, 443-453 (1990).
24. OKADA, F., RAK, J.W., ST. CROIX, B., LIEUBEAU, B., KAYA, M., RONCARI, L., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R.S., Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. nat. Acad. Sci. (Wash). 95, 3609-3614 (1998).
25. PLATE, K.H., BREIER, G., WEICH, H.A. and RISAU, W., Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond). 359, 845-848 (1992).
26. RAK, J., MITSUHASHI, Y., BAYKO, L., FILMUS, J., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R.S., Mutant ras oncogenes upregulate VEGFA/PF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55, 4575-4580 (1995).
27. SEMENZA, G.L., JIANG, B.H., LEUNG, S.W., PASSANTINO, R., CONCORDET, J.P., MAIRE, P. and GIALLONGO, A., Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. biol. Chem., 271, 32529-32537 (1996).
28. SHAW, G. and KAMEN, R.A., A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46, 659-667 (1986).
29. SHIFREN, J.L., TSENG, J.F., ZALOUDEK, C.J., RYAN, I.P., MENG, Y.G., FERRARA, N., JAFFE, R.B. and TAYLOR, R.N., Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. clin. Endocrinol. Metab., 81, 3112-3118 (1996).
30. SHWEIKI, D., ITIN, A., SOFFER, D. and KESHET, E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359, 843-845 (1992).
31. SHWEIKI, D., NEEMAN, M., ITIN, A. and KESHET, E., Induction of vascular endothelial growth factor expression by hypoxia and by glucose deprivation in multicell spheroids: implications for tumor angiogenesis. Proc. nat. Acad. Sci. (Wash.). 92, 768-772 (1995).
32. TISCHER, E., MITCHELL, R., HARTMAN, T., SILVA, T., GOSPODAROWICZ, D., FIDDES, J.C. and ABRAHAM, J.A., The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. biol. Chem., 266, 11946-11954 (1991).
33. VAISMAN, N., GOSPODAROWICZ, D. and NEUFELD, G., Characterization of the receptors for vascular endothelial growth factor. J. biol. Chem., 265, 19461-19466 (1990).
34. WARREN, R.S., YUAN, H., MATLI, M.R., FERRARA, N. and DONNER, D.B., Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. biol. Chem., 271, 29483-29488 (1996).